Genetic and epigenetic influence on EAE phenotypes induced with different encephalitogenic peptides

Journal of Neuroimmunology

Volumn 108, Issue 1-2, 2000, Pages 45-52

  Sobel, Raymond A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Experimental autoimmune encephalomyelitis; Genetics; Major histocompatibility complex; Multiple sclerosis; Proteolipid protein

Indexed keywords

AUTOANTIGEN; ENCEPHALITOGENIC PROTEIN; PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETICS; HISTOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ACUTE DISEASE; ANIMALS; ANTIGENS; BRAIN STEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENOTYPE; INFLAMMATION; MICE; MICE, INBRED STRAINS; MYELIN PROTEOLIPID PROTEIN; PARALYSIS; PEPTIDE FRAGMENTS; PHENOTYPE; SPINAL CORD;

EID: 0034255884     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00270-2     Document Type: Article

References (47)

1. Abromson-Leeman, S., Bronson, R., Dorf, M.E., 1995. Experimental autoimmune peripheral neuritis induced in BALB/c mice by myelin basic protein-specific T cell clones. J. Exp. Med. 182, 587-592.
2. Berger, T., Weerth, S., Kojima, K., Linington, C., Wekerle, H., Lassmann, H., 1997. Experimental autoimmune encephalomyelitis: The antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab. Invest. 76, 355-364.
3. + T cells. Science 281, 1352-1354.
4. Butterfield, R.J., Blankenhorn, E.P., Roper, R.J., Zachary, J.F., Doerge, R.W., Sudweeks, J., Rose, J., Teuscher, C., 1999. Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): Relapsing/remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct. J. Immunol. 162, 3096-3102.
5. Chang, T., Jabs, C., Sobel, R.A., Kuchroo, V.K., Sharpe, A.H., 1999. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. J. Exp. Med. 190, 733-740.
6. Das, M.P., Nicholson, L.B., Greer, J., Kuchroo, V.K., 1997. Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein. J. Exp. Med. 186, 867-876.
7. Encinas, J., Lees, M.B., Sobel, R.A., Symonowicz, C., Greer, J.M., Shovlin, C.L., Weiner, H.L., Seidman, C.E., Seidman, J.G., Kuchroo, V.K., 1996a. Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. J. Immunol. 157, 2186-2192.
8. Encinas, J.A., Weiner, H.L., Kuchroo, V.K., 1996b. Inheritance of susceptibility to experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45, 655-669.
9. Encinas, J.A., Wicker, L.S., Peterson, L.B., Mukasa, A., Teuscher, C., Sobel, R., Seidman, C.E., Seidman, J.G., Kuchroo, V.K., 1999. Colocalization of QTL influencing both autoimmune diabetes and autoimmune encephalomyelitis to a 0.15 cM region on mouse chromosome 3. Nat. Genet. 21, 158-160.
10. Endoh, M., Kunishita, T., Nihei, J., Nishizawa, M., Tabira, T., 1990. Susceptibility to proteolipid apoprotein and its encephalitogenic determinants in mice. Int. Arch. Allergy Appl. Immunol. 92, 433-438.
11. Genain, C.P., Cannella, B., Hauser, S.L., Raine, C.S., 1999. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med. 5, 170-175.
12. Greer, J.M., Sobel, R.A., Sette, A., Southwood, S., Lees, M.B., Kuchroo, V.K., 1996. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J. Immunol. 156, 371-379.
13. Greer, J.M., Csurhes, P.A., Cameron, K.D., McCombe, P.A., Good, M.F., Pender, M.P., 1997a. Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis. Brain 120, 144-160.
14. Greer, J.M., Klinguer, C., Trifilieff, E., Sobel, R.A., Lees, M.B., 1997b. Encephalitogenicity of murine but not bovine DM20 in SJL/J mice is due to a single amino acid substitution. Neurochem. Res. 22, 541-547.
15. Greer, J.M., Kuchroo, V.K., Sobel, R.A., Lees, M.B., 1992. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J. Immunol. 149, 783-788.
16. Henikoff, S., Matske, M.A., 1997. Exploring and explaining epigenetic effects. Trends Genet. 13, 293-295.
17. Holländer, G.A., Zuklys, S., Morel, C., Mizoguchi, E., Mobisson, K., Simpson, S., Terhorst, C., Wishart, W., Golan, D.E., Bhan, A.K., Burakoff, S.J., 1998. Monoallelic expression of the interleukin-2 locus. Science 279, 2118-2121.
18. Holmdahl, R., 1998. Genetics of susceptibility to chronic experimental encephalomyelitis and arthritis. Curr. Opin. Immunol. 10, 710-717.
19. Jemison, L.M., Williams, S.K., Lublin, F.D., Knobler, R.L., Korngold, R., 1993. Interferon-γ-inducible endothelial cell class II major histocompatibility complex expression correlates with strain- and site-specific susceptibility to experimental allergic encephalomyelitis. J. Neuroimmunol. 47, 15-22.
20. Johnson, D., Yasui, D., Seeldrayers, P., 1991. An analysis of mast cell frequency in the rodent nervous system: Numbers vary between different strains and can be reconstituted in mast cell-deficient mice. J. Neuropathol. Exp. Neurol. 50, 227-234.
21. Lando, Z., Teitelbaum, D., Arnon, R., 1980. Induction of experimental allergic encephalomyelitis in genetically resistant strains of mice. Nature 287, 551-552.
22. Martin, R., 1997. Genetics of multiple sclerosis - How could disease-associated HLA-types contribute to pathogenesis? J. Neural. Trans. 49 (Suppl.), 177-194.
23. McRae, B.L., Vanderlugt, C.L., Dal Canto, M.C., Miller, S.D., 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182, 75-85.
24. Mokhtarian, F., Zhang, Z., Shi, Y., Gonzales, E., Peng, J.H., Sobel, R.A., 1999. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. J. Neuroimmunol. 95, 43-54.
25. Montgomery, I.N., Rauch, H.C., 1982. Experimental allergic encephalomyelitis (EAE) in mice: Primary control of EAE susceptibility is outside the H-2 complex. J. Immunol. 128, 421-425.
26. Morel, L., Tian, X.-H., Croker, B.P., Wakeland, E.K., 1999. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 11, 131-138.
27. Moudgil, K.D., Wang, J., Yeung, V.P., Sercarz, E.E., 1998. Heterogeneity of the T cell response to immunodominant determinants within hen eggwhite lysozyme of individual syngeneic hybrid F1 mice: Implications for autoimmunity and infection. J. Immunol. 161, 6046-6053.
28. Muller, D., Pender, M.P., Greer, J.M., 2000. A detailed neuropathological analysis of a form of experimental autoimmune encephalomyelitis with predominant brainstem and cerebellar involvement, Acta Neuropathol. (Berl.), in press.
29. Noseworthy, J.H., 1999. Progress in determining the causes and treatment of multiple sclerosis. Nature 399 (Suppl.), A40-A47.
30. Nygard, N.R., McCarthy, D.M., Schiffenbauer, J., Schwartz, B.D., 1993. Mixed haplotypes and autoimmunity. Immunol. Today 14, 53-56.
31. Pender, M.P., Tabi, Z., Nguyen, K.B., McCombe, P.A., 1995. The proximal peripheral nervous system is a major site of demyelination in experimental autoimmune encephalomyelitis induced in the Lewis rat by a myelin basic protein-specific T cell clone. Acta Neuropathol. (Berl.) 89, 527-531.
32. Perrin, P.J., Lavi, E., Rumbley, C.A., Zekavat, S.A., Phillips, S.M., 1999. Experimental autoimmune meningitis: A novel neurological disease in CD28-deficient mice. Clin. Immunol. 91, 41-49.
33. Prineas, J.W, McDonald, WI., 1997. Demyelinating diseases. In: Graham, I., Lantos, PL. (Eds.), Greenfield's Neuropathology, 6th Edition. Oxford University Press, New York, pp. 813-896.
34. Satoh, J., Saki, K., Endoh, M., Koike, F., Kunishita, T., Namikawa, T., Yamamura, T., Tabira, T., 1987. Experimental allergic encephalomyelitis mediated by murine encephalitogenic T cell lines specific for myelin proteolipid apoprotein. J. Immunol. 138, 179-184.
35. Smith-Norowitz, T., Sobel, R.A., Mokhtarian, F., 2000. B cells and antibodies in the pathogenesis of myelin injury in Semliki Forest Virus encephalomyelitis, Cell Immunol., in press.
36. Sobel, R.A., Colvin, R.B., 1985. The immunopathology of acute experimental allergic encephalomyelitis. III. Differential in situ expression of Strain 13 Ia on endothelial and inflammatory cells of (Strain 2XStrain 13) F1 guinea pigs with EAE. J. Immunol. 134, 2333-2337.
37. 1 mice with acute experimental allergic encephalomyelitis induced with two different synthetic peptides of myelin proteolipid protein. J. Immunol. 146, 543-549.
38. Sobel, R.A., Tuohy, V.K., Lu, Z., Laursen, R.A., Lees, M.B., 1990. Acute experimental allergic encephalomyelitis in SJL/J mice induced by a synthetic peptide of myelin proteolipid protein. J. Neuropathol. Exp. Neurol. 49, 468-479.
39. Stevens, D.B., Chen, K., Seitz, R.S., Sercarz, E.E., Bronstein, J.M., 1999. Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 162, 7501-7509.
40. Takács, K., Chandler, P., Altmann, D.M., 1997. Relapsing and remitting experimental allergic encephalomyelitis: A focused response to the encephalitogenic peptide rather than epitope spread. Eur. J. Immunol. 27, 2927-2934.
41. Tuohy, V.K., Sobel, R.A., Lees, M.B., 1988. Myelin proteolipid protein-induced experimental allergic encephalomyelitis: Variations of disease expression in different strains of mice. J. Immunol. 140, 1868-1873.
42. Tuohy, V.K., Yu, M., Yin, L., Kawczak, J.A., Kinkel, R.P., 1999. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 189, 1033-1042.
43. Vyse, T.J., Kotzin, B.L., 1998. Genetic susceptibility to systemic lupus erythematosus. Ann. Rev. Immunol. 16, 261-292.
44. Weinshenker, B.G., Santrach, P., Bissonet, A.S., McDonnell, S.K., Schaid, D., Moore, S.B., Rodriguez, M., 1998. Major histocompatibility complex class II alleles and the course and outcome of MS: A population-based study. Neurology 51, 742-747.
45. Welsh, J., Sapatino, B., Rosenbaum, B., Smith, R., Linthicum, S., 1993. Correlation between susceptibility to demyelination and interferon-γ induction of major histocompatibility complex class II antigens on murine cerebrovascular endothelial cells. J. Neuroimmunol. 48, 91-97.
46. Yasuda, T., Tsumita, T., Nagai, Y., Mitsuzawa, E., Ohtani, S., 1975. Experimental allergic encephalomyelitis (EAE) in mice. I. Induction of EAE with mouse spinal cord homogenate and myelin basic protein. Jpn. J. Exp. Med. 45, 423-427.
47. Yong, T., Bebo, Jr. B.F., Sapatino, V.B., Welsh, C.J., Orr, E.L., Linthicum, D.S., 1994. Histamine-induced microvascular leakage in pial venules: Differences between the SJL/J and BALB/c inbred strains of mice. J. Neurotrauma 11, 161-171.